Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciara L Freeman

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Journal of Cancer Policy|May 13, 2022
Health-related quality of life data collected in chimeric antigen receptor T-cell (CAR-T) therapy clinical trialsAdam J N Raymakers, Dean A Regier, Stuart J Peacock, et al.
Lancet (London, England)|August 29, 2017
Soft tissue plasmacytomas in multiple myelomaDavid P Breen, Ciara L Freeman, Rajith N De Silva, et al.
Expert Opinion on Investigational Drugs|August 13, 2013
Perifosine--a new option in treatment of acute myeloid leukemia?Janusz Krawczyk, Niamh Keane, Ronan Swords, et al.
Blood Advances|May 26, 2023
CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial responseOthman S Akhtar, Biwei Cao, Xuefeng Wang, et al.
Blood|March 18, 2025
Prognostic Biomarkers in MCL: Insights from the SHINE Trial on the impact of MCL35 score and TP53 Mutation StatusCiara L Freeman, Srimathi Srinivasan, Brendan Hodkinson, et al.
The Journal of the American Academy of Orthopaedic Surgeons|September 15, 2025
Influence of Chimeric Antigen Receptor T-Cell Therapy on Fracture Risk of Patients With Multiple MyelomaThien Huong N Huynh, Bryan A Clampitt, Chloe M Chose, et al.
Blood Advances|August 1, 2020
Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphomaDiego Villa, Laurie H Sehn, Kerry J Savage, et al.
British Journal of Haematology|August 12, 2022
Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British ColumbiaRehan Jessa, Nicole Chien, Diego Villa, et al.
Blood|October 9, 2015
Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactionsCiara L Freeman, Franck Morschhauser, Laurie Sehn, et al.
Leukemia & Lymphoma|June 24, 2022
Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphomaManik Chahal, Anna Hayden, Kerry J Savage, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Journal of Cancer Policy|May 13, 2022
Health-related quality of life data collected in chimeric antigen receptor T-cell (CAR-T) therapy clinical trialsAdam J N Raymakers, Dean A Regier, Stuart J Peacock, et al.
Lancet (London, England)|August 29, 2017
Soft tissue plasmacytomas in multiple myelomaDavid P Breen, Ciara L Freeman, Rajith N De Silva, et al.
Expert Opinion on Investigational Drugs|August 13, 2013
Perifosine--a new option in treatment of acute myeloid leukemia?Janusz Krawczyk, Niamh Keane, Ronan Swords, et al.
Blood Advances|May 26, 2023
CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial responseOthman S Akhtar, Biwei Cao, Xuefeng Wang, et al.
Blood|March 18, 2025
Prognostic Biomarkers in MCL: Insights from the SHINE Trial on the impact of MCL35 score and TP53 Mutation StatusCiara L Freeman, Srimathi Srinivasan, Brendan Hodkinson, et al.
The Journal of the American Academy of Orthopaedic Surgeons|September 15, 2025
Influence of Chimeric Antigen Receptor T-Cell Therapy on Fracture Risk of Patients With Multiple MyelomaThien Huong N Huynh, Bryan A Clampitt, Chloe M Chose, et al.
Blood Advances|August 1, 2020
Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphomaDiego Villa, Laurie H Sehn, Kerry J Savage, et al.
British Journal of Haematology|August 12, 2022
Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British ColumbiaRehan Jessa, Nicole Chien, Diego Villa, et al.
Blood|October 9, 2015
Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactionsCiara L Freeman, Franck Morschhauser, Laurie Sehn, et al.
Leukemia & Lymphoma|June 24, 2022
Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphomaManik Chahal, Anna Hayden, Kerry J Savage, et al.
Pageof 7